Dr. John F. Zwetchkenbaum, M.D.
Allergy & Immunology (Allergy Physician)
1056 Hope St
Providence, RI 02906
Who else practices at this address →
Providence County includes mental health (6% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Boston University School of Medicine (1985)
- Years since graduation
- 41
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 245
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1985Medical school: Boston University School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Allergy Physician primary
RI license MD07704
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- The Miriam Hospital Providence, RI
- Kent County Memorial Hospital Warwick, RI
Medical groups
- Asthma and Allergy Physicians of Rhode Island Inc (3 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 245
- Services billed
- 9,376
- Patients’ average age
- 72
| Service | Times | Patients |
|---|---|---|
| Test for allergy using allergenic extract | 5,128 | 79 |
| Test for allergy using skin patch | 1,471 | 18 |
| Test for allergy using allergenic extract injected into skin | 1,186 | 62 |
| Professional service for multiple injections of allergen | 577 | 38 |
| Professional service for preparation and provision of 1 or more antigens | 405 | 36 |
| Established patient office or other outpatient visit, 20-29 minutes | 170 | 133 |
| Test to measure expiratory airflow and volume | 118 | 81 |
| Professional service for single injection of allergen | 77 | 13 |
| Established patient office or other outpatient visit, 30-39 minutes | 42 | 37 |
| New patient office or other outpatient visit, 30-44 minutes | 39 | 39 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Fluticasone Propionate Other prescribers in Providence, RI | 182 |
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Providence, RI | 171 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Providence, RI | 147 |
| Azelastine Hcl Other prescribers in Providence, RI | 125 |
| Levocetirizine Dihydrochloride Other prescribers in Providence, RI | 124 |
| Montelukast Sodium Other prescribers in Providence, RI | 110 |
| Arnuity Ellipta (fluticasone furoate) Other prescribers in Providence, RI | 96 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Providence, RI | 91 |
| Wixela Inhub (fluticasone propion/salmeterol) Other prescribers in Providence, RI | 66 |
| Cromolyn Sodium | 60 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 11 companies reported 23 payments worth $590 in total to this clinician.
| GlaxoSmithKline, LLC. | $261 |
|---|---|
| Novartis Pharmaceuticals Corporation | $74.31 |
| Ars Pharmaceuticals Operations, Inc. | $47.49 |
| Csl Behring | $33.99 |
| Pfizer Inc. | $30.17 |
| Takeda Pharmaceuticals U.S.A., Inc. | $29.45 |
| Paratek Pharmaceuticals, Inc. | $27.21 |
| Organon LLC | $24.99 |
| Food and Beverage | $590 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 7 industry-funded studies in 2025, from 4 companies. The companies reported $176,897 in research payments for these studies, mostly to the institutions running them.
- A phase 3, 24-week, randomized, double-blind, placebo-controlled, para
GlaxoSmithKline, LLC. - A multicentre, randomized, double-blind, placebo-controlled, dose find
GlaxoSmithKline, LLC. - BRISOTE A Multicentre Randomised DoubleBlind Parallel Group ActiveControlled Phase 3b Study to Evaluate the Efficacy and Safety of Benralizumab 30 mg SC in Eosinophilic Asthma Patients Uncontrolled on Medium Dose Inha…
AstraZeneca UK Limited - A randomized, single-dose, double-blind, placebo-controlled, four-way crossover, multicenter bronchoprovocation study comparing the bronchoprotective effects of albuterol sulfate inhalation aerosol (90 mcg, invagen/ci…
Cipla USA Inc. - A prospective, real-world, interventional study to evaluate the effect
GlaxoSmithKline, LLC. - Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Sanofi US Services Inc. · Recruiting · NCT07143669 - A phase 3, 52-week, randomized, double-blind, placebo-controlled, para
GlaxoSmithKline, LLC.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.